AGN: Saunders was on Cramer/CNBC this evening. He said he took the chin treatment himself from trained dermatologist. It took ~90 seconds, 50? separate injections, no pain[details from my memory].
AGN CEO admits that Kybella—the double-chin drug—has fallen far short of commercial expectations. On today's Barclays webcast, Brent Saunders said that many Kybella patients have so much swelling and redness they never return for a second injection, and hence they don't show much cosmetic benefit from the single treatment.
Market Data 
Markets 
AI
